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Abstract BRCA1/2 mutation carriers have a high lifetime
risk of developing breast cancer. Differences in penetrance
indicate that this risk may be influenced by lifestyle factors.
Because physical activity is one of the few modifiable risk
factors, it may provide a target to add to breast cancer pre-
vention in this high-risk population. We examined the
association between self-reported lifetime sports activity and
breast cancer risk in a nationwide retrospective cohort study,
including 725 carriers, of whom 218 had been diagnosed
with breast cancer within 10 years prior to question-
naire completion. We found a nonsignificantly decreased
risk for ever engaging in sports activity (HR = 0.84,
95%CI = 0.57–1.24). Among women who had participated
in sports, a medium versus low level of intensity and dura-
tion (i.e., between 11.0 and 22.7 mean MET hours/week
averaged over a lifetime) reduced the risk of breast cancer
(HR = 0.59, 95%CI = 0.36–0.95); no dose–response
trend was observed. For mean hours/week of sports activity,
a nonsignificant trend was observed (HRlow versus never =
0.93, 95%CI = 0.60–1.43; HRmedium versus never = 0.81,
95%CI = 0.51–1.29; HRhigh versus never = 0.78, 95%CI =
0.48–1.29; ptrend overall = 0.272; ptrend active women = 0.487).
For number of years of sports activity no significant associ-
ations were found. Among women active in sports before age
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30, mean MET hours/week showed the strongest inverse
association of all activity measures (HRmedium versus low =
0.60, 95%CI = 0.38–0.96; HRhigh versus low = 0.58,
95%CI = 0.35–0.94; ptrend = 0.053). Engaging in sports
activity after age 30 was also inversely associated with breast
cancer risk (HR = 0.63, 95%CI = 0.44–0.91). Our results
indicate that sports activity may reduce the risk of breast
cancer in BRCA1/2 mutation carriers.
Keywords Physical activity  Breast cancer  BRCA1/2 
HEBON  Epidemiology
Introduction
The lifetime risk estimates for breast cancer in BRCA1/2
mutation carriers vary from 30 to 80% [1–7]. Differences in
penetrance between generations, together with differences
in age at onset and phenotypic expression between and
within BRCA1/2 families, indicate that the risk of breast
cancer may also be influenced by modifying genes and by
environmental and lifestyle factors (with changing preva-
lence over time) [8]. It is well established that increased
levels of physical activity decrease the risk of breast cancer
in the general population by approximately 20–40% [9–13].
The association is most pronounced for postmenopausal
women, although several recent large prospective cohort
studies concluded that increased physical activity may
decrease the risk for premenopausal breast cancer as well
[14–16]. Because physical activity is one of the few mod-
ifiable risk factors, it may provide a target to add to breast
cancer prevention in this high-risk population.
Only two small studies investigated physical activity
and breast cancer risk in BRCA1/2 carriers [6, 17]. In a
case–case study (N = 104) [6], teenage sports activity (yes
vs. no) was associated with a 10-year delay in breast cancer
onset (univariate analyses). An unmatched case–control
study (N = 137) [17] investigated recent leisure-time
physical activity and breast cancer risk and observed no
apparent association. To our knowledge, this is the first
large study specifically examining physical activity and
breast cancer risk in BRCA1/2 mutation carriers.
Materials and methods
Study population
The present study is part of an ongoing nationwide study
[HEreditary Breast and Ovarian cancer study, the Nether-
lands (HEBON study)] among members of BRCA1/2 fam-
ilies in the Netherlands. The general design includes a
retrospective cohort [because the BRCA1/2 DNA test is
available only fairly recently (1995)] with a prospective
follow-up. BRCA1/2 families were identified through ten
centers [nine Clinical Genetic Centers (CGCs)/Family
Cancer Clinics and the Foundation for the Detection of
Hereditary Tumours (STOET)]. The study was approved by
the medical ethics committees of all participating centers.
Female family members were eligible if they (a) carried a
BRCA1 or BRCA2 mutation; (b) were alive and had no
personal history of breast and/or ovarian cancer on January 1,
1960, or born after 1960; and (c) were at age 18 or older at
study entry. A self-administered risk factor questionnaire
was mailed to eligible individuals by their clinical geneticist
in the period of January 1999 to August 2007. To reduce
potential survival bias, a close relative was asked to complete
a shorter version of the standard questionnaire (proxy
questionnaire) for eligible individuals who had died.
Informed consent was obtained from each individual (or
their proxy). Information on cancer history and prophylactic
surgeries was either self-reported for the period not covered
by the registries (\1989) and/or collected through the
Netherlands Pathology Database (PALGA) [18] and the
Netherlands Cancer Registry (NCR) until August 2007.
Ninety-five percent of breast cancers diagnosed after 1988
were confirmed by PALGA/NCR. Information on deaths
was retrieved through municipal registries.
The initial cohort consisted of 1,120 BRCA1/2 mutation
carriers (response 80%; among proxies 76%). For 26% of
eligible deceased carriers (n = 299), we could not find a
proxy. We excluded seven carriers of whom the age at end
of follow-up was missing (n = 7), and for reliability rea-
sons we also excluded carriers of whom at least 50% of
physical activity information was missing [n = 87, of
which 53 (62%) were proxy questionnaires]. This resulted
in an entire cohort of 1,026 carriers, of whom 468 had been
diagnosed with breast cancer.
Analytic cohort
Physical activity is related to overall survival [19, 20] and
breast cancer-related survival [21–23]. Consequently, in
this study population of women at high risk of cancer death,
prevalent cases that were relatively active may have been
overrepresented in our entire cohort, leading to bias toward
unity (assuming physical activity reduces breast cancer
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risk). Therefore, to reduce potential survival bias, we
restricted the analysis to person-years within 10 years prior
to questionnaire completion [24–26]. In total, 218 cases
were diagnosed with breast cancer within the 10-year period.
The cohort included 20 obligate carriers (not tested them-
selves but considered as carrier because they had at least one
proven carrier among their children, while inheritance was
not paternal). Five percent (n = 37) of the questionnaires in
the analytic cohort was completed by proxies.
Assessment of sports activity
For each sport practiced over a lifetime, we collected
information on type of sport, number of hours spent per
week, and ages at which it was practiced. Women were
instructed to report only sports activities that were per-
formed for at least 6 months for 1 h per week. The detailed
information allowed us to analyze the data time-varying.
To investigate the intensity of activity, we assigned a
metabolic equivalent (MET) value to each reported activity
according to the compendium by Ainsworth et al. [27, 28].
Statistical analysis
The adjusted hazard ratios (HRs) as estimates of relative risk
and 95% confidence intervals (95%CI) were obtained using
a time-varying, multivariable Cox proportional hazards
model with age (in years) as time scale. Follow-up started at
10 years prior to questionnaire completion and ended at date
of first breast cancer diagnosis, date of bilateral prophylactic
mastectomy, date of linkage with PALGA/NCR, date of
completing the questionnaire if no informed consent for
linkage was given, or date of death, whichever occurred
first. All analyses were adjusted for age at the start of follow-
up, intrinsically stratified for birth cohort (\1943, 1943–
1954, 1955–1963, [1963) and gene (BRCA1 and BRCA2)
and clustered on family to correct for potential within-
family correlations in risk factors. Additionally, all analyses
were weighted according to the weighted cohort approach to
correct for potential testing bias [29].
We investigated average lifetime sports activity, sports
activity before and after age 30 (cutoff was based on power
issues), and recent sports activity in different time windows
(1, 2, 5, and 10 years). We analyzed three measures of
sports activity for all active years: mean hours per week,
mean MET hours/week, and number of active years.
Number of active years counts any sport activity. Sports
activity was categorized into four groups: a nonactive
group and three physically active groups (tertiles) based on
the (average) activity level at end of follow-up in breast
cancer cases in order to maximize power. The nonactive
women were considered as the reference group. To disen-
tangle independent effects of the three measures of sports
activity, we examined the association with breast cancer
risk among women active in sports with women in the
lowest tertile as the reference group. In this way we could
simultaneously include mean MET hours/week or mean
hours per week with number of active years in the model.
Only exposure information in the period at risk (before the
end of follow-up) was considered.
For the multivariate models, forward stepwise con-
founder selection, in which the effect of adding one con-
founder at a time was evaluated, was based on a more than
10% change in (at least one of) the b-estimates of the main
exposure variables: ever/never lifetime sports activity,
mean MET hours/week, and number of active years. Con-
founders (categorized based on the distribution in the entire
cohort at the end of follow-up) were menopausal status, use
of oral contraceptives, use of hormonal replacement therapy
(HRT), body mass index (BMI) at age 18, age-specific BMI,
parity, and alcohol consumption. For lifetime sports activ-
ity, the multivariate models were also adjusted for occu-
pational activity (mean MET hours/week), which was based
on the hours per week spent on the longest held occupation,
the period it was practiced, and its intensity (sedentary,
standing, or vigorous). Age at menarche, age at first full
term pregnancy, breast-feeding, educational level, smoking,
and family history did not change the b-estimates by more
than 10% and were omitted from our final model. No vio-
lation of the proportional hazards assumption by any of the
variables was observed.
All analyses were also performed for premenopausal
women separately, using the same age at censoring as
before or age at menopause, whichever occurred first. Two-
sided p-values B0.05 were considered statistically signifi-
cant. All analyses were performed using STATA/SE 10.0
(StataCorp LP).
Results
The characteristics of the study population are summarized
in Table 1. The mean age at end of follow-up was
44.5 ± 13.3 years, and there was no difference between
cases and noncases (p = 0.277). The mean age at ques-
tionnaire completion was 45.5 ± 12.7 years (cases were
older than noncases: 48.1 ± 10.6 versus 44.4 ± 13.3 years,
p \ 0.001; proxy data excluded). Seventy-nine percent of
women had ever participated in sports activity (69 and 85%
among women were born before and after 1955, respec-
tively). In active periods, the median MET hours/week of
sports activity in active periods throughout life was 17.0
[which equals, for example, about 2.5 h of tennis
(MET = 7.0) per week]. The median number of hours of
sports activity per week was 2.7, and the median number of
active years was 16.
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The estimated hazard ratios for the association between
average lifetime sports activity and the risk of breast cancer
are presented in Table 2. We observed a nonsignificant risk
reduction for ever engaging in lifetime sports activity
(HR = 0.84, 95%CI = 0.57–1.24). Overall, a medium
level of intensity and duration (mean MET hours/week
averaged over a lifetime) of sports activity was associated
with a risk reduction (HR = 0.64, 95%CI = 0.38–1.06)
when compared to never sports activity. A medium level
was defined as between 11.0 and 22.7 MET hours/week,
which equals, e.g., 1.6 to 3.2 h of tennis. Among active
women, a medium level of intensity and duration of sports
(corrected for number of active years) was associated with a
risk reduction (HR = 0.59, 95%CI = 0.36–0.95) when
compared to a low level while for a high level the risk was
not significantly decreased (HR = 0.77, 95%CI = 0.64–
1.27). For mean hours of sports activity per week (corrected
for number of active years), a nonsignificant trend was
Table 1 Characteristics of the study population (N = 725)
Characteristic Cohort (n = 725) Cases (n = 218)
No.a (%) No.a (%)
Gene
BRCA1 558 (77) 170 (78)
BRCA2 167 (23) 48 (22)
Carrier type
Proven 705 (98) 213 (98)
Obligate 20 (3) 6 (2)
Proxy data
No 688 (95) 203 (93)
Yes 37 (5) 15 (7)
Birth cohort
\1943 101 (14) 31 (14)
1943–1954 165 (23) 67 (31)
1955–1963 199 (27) 66 (30)
[1963 260 (36) 54 (25)
Age at end of follow-up
\35 years 180 (25) 51 (23)
35–41 years 159 (22) 47 (22)
42–50 years 180 (25) 61 (28)
[50 years 206 (28) 60 (28)
Age at menarche
B12 years 232 (33) 77 (36)
13 years 183 (26) 51 (24)
C14 years 291 (41) 84 (40)
Parity
Nulliparous 185 (26) 47 (22)
Parous 540 (74) 171 (78)
Number of children
1–2 children 365 (68) 128 (75)
[2 children 175 (32) 43 (25)
Age at first full term pregnancy
\24 years 143 (27) 55 (32)
24–28 years 185 (34) 53 (31)
C28 years 212 (39) 63 (37)
Breast-feeding
Never 137 (25) 46 (27)
Ever 402 (75) 125 (73)
Age-specific BMI (kg/m2)
\22 227 (32) 71 (33)
22–25 239 (33) 68 (32)
C25 251 (36) 76 (35)
BMI at age 18 (kg/m2)
\19.6 244 (34) 72 (33)
19.6–21.8 237 (33) 74 (34)
C21.8 244 (34) 72 (33)
Oral contraceptive use
Never 92 (13) 23 (11)
Ever 631 (87) 194 (89)
Table 1 continued
Characteristic Cohort (n = 725) Cases (n = 218)
No.a (%) No.a (%)
Menopausal status
Premenopausal 417 (58) 155 (71)
Postmenopausal 308 (42) 63 (29)
Type of menopause
Natural 138 (45) 49 (78)
Surgical, prophylactic 138 (45) 13 (21)
Surgical, ovarian cancer 26 (8) 1 (1)
Unknown 6 (2) 0 (0)
HRT use
Never 211 (69) 46 (73)
Ever 93 (31) 27 (27)
Alcohol consumption
Never 290 (40) 92 (43)
Ever 433 (60) 124 (57)
Smoking
Never 336 (46) 100 (46)
Ever 389 (54) 118 (54)
Educational level
Low 281 (39) 90 (42)
Medium 241 (34) 62 (29)
High 197 (27) 63 (29)
Family history
No 301 (43) 80 (37)
Yes 405 (57) 135 (63)
a Numbers do not always add up to 100% due to missing values;
Number of children, Age at first full term pregnancy and Breast-
feeding apply to parous women only (100%); Type of menopause and
HRT use apply to postmenopausal women only (100%)
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observed (HRlow versus never = 0.93, 95%CI = 0.60–1.43;
HRmedium versus never = 0.81, 95%CI = 0.51–1.29; HRhigh
versus never = 0.78, 95%CI = 0.48–1.29; ptrend overall =
0.272; ptrend active women = 0.487). For number of active
years of sports activity no significant associations were
found.
Ever versus never having participated in sports activity
before age 30 was not associated with breast cancer risk
(Table 3). However, among women active in sports before
age 30, we observed stronger risk reductions for increasing
levels of sports activity. The inverse association was most
clear for mean MET hours/week (HRmedium versus low = 0.60,
95%CI = 0.38–0.96; HRhigh versus low = 0.58, 95%CI =
0.35–0.94, ptrend = 0.053). For sports activity after age 30,
we found that any activity was associated with a risk
reduction of breast cancer (HR = 0.63, 95%CI = 0.44–
0.91). No dose–response trends were observed for any of the
aspects of sports activity after age 30. Additional adjustment
for sports activity in the other periods did not materially
affect the results (data not shown).
For recent sports activity (Table 4), the associations
were less strong but similar to those found for sports
activity after age 30 (Table 3). Furthermore, no differences
between the different time windows were observed.
Effect modification by age-specific BMI (\23.8
and C23.8 kg/m2) was investigated by stratified (unweigh-
ted) analysis (data not shown). When compared to the
unweighted results (data not shown), the inverse associations
were somewhat more pronounced for relatively lean women
but the differences were small. The largest discrepancy was
observed for sports participation after age 30: the HRs were
0.58 (95%CI = 0.38–0.88) and 0.75 (95%CI = 0.49–1.15)
in lean and heavy women, respectively.
The analyses restricted to premenopausal carriers and
BRCA1 carriers yielded essentially the same results (data
not shown).
Table 2 Lifetime sports activity and the risk of breast cancer (N = 725)
Person-years Cases Multivariate
HR (95% CI)a HR (95% CI)b
Lifetime sports activity
Never 1,199 46 1.00 –
Ever 4,726 172 0.84 (0.57–1.24)
Mean MET hours/week
Low (\11.0) 1,255 54 1.06 (0.70–1.59) 1.00
Medium (11.0–22.7) 1,788 52 0.64 (0.38–1.06) 0.59 (0.36–0.95)
High (C22.7) 1,683 66 0.83 (0.50–1.37) 0.77 (0.48–1.24)
ptrend 0.286 0.494
Mean hours/week
Low (\2.0) 1,280 53 0.93 (0.60–1.43) 1.00
Medium (2.0–3.3) 1,732 53 0.81 (0.51–1.29) 0.88 (0.56–1.39)
High (C3.3) 1,714 66 0.78 (0.48–1.29) 0.85 (0.54–1.34)
ptrend 0.272 0.487
Number of active years
\9 years 821 36 0.80 (0.49–1.31) 1.00
9–19 years 1,607 59 0.89 (0.55–1.43) 1.21 (0.72–2.03)
C19 2,298 77 0.83 (0.52–1.30) 1.11 (0.67–1.85)
ptrend 0.468 0.820
Missing values (\4%) were coded as an additional level to include as many participants as possible for the adjustment factors. Test for trend were
conducted on the medians of the categories of sports activity
HR Hazard ratio, CI confidence interval
a A weighted time-varying Cox proportional hazards model, stratified for genes (BRCA1 and BRCA2) and birth cohort (\1943, 1943–1954,
1955–1963, [1963), and clustered on family (404 clusters) with never sports activity as the reference category. The models are adjusted for use
of oral contraceptives (never/ever), parity (nulliparous, 1–2 children, [2 children), menopausal status (premenopausal, natural menopause,
surgical prophylactic, surgical ovarian cancer; time-varying), HRT use (never/ever), age-specific BMI (\22, 22–25, C25 kg/m2; time-varying),
BMI at age 18 (\19.6, 19.6–21.8, C21.8 kg/m2), alcohol consumption (never/ever), and occupational activity (mean MET hours/week)
b As model awith the lowest sports activity category as the reference category and adjusted for activity (yes/no). The models for mean MET
hours/week and mean hours/week were additionally adjusted for number of active years, and the models for number of active years were
additionally adjusted for mean MET hours/week
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Table 3 Sports activity before and after age 30 and the risk of breast cancer (N = 725)a
Period Activity Person-years Cases Multivariate
HR (95% CI)b HR (95% CI)c
Before age 30 Sports activity
Never 1,692 62 1.00 –
Ever 4,233 156 1.01 (0.69–1.49)
Mean MET hours/week
Low (\10.6) 1,111 51 1.43 (0.94–2.17) 1.00
Medium (10.6–21.7) 1,434 45 0.83 (0.52–1.33) 0.60 (0.38–0.96)
High (C21.7) 1,688 60 0.77 (0.46–1.28) 0.58 (0.35–0.94)
ptrend 0.113 0.053
Mean hours/week
Low (\2.0) 1,128 49 1.32 (0.85–2.06) 1.00
Medium (2.0–3.3) 1,481 49 0.91 (0.58–1.42) 0.70 (0.43–1.14)
High (C3.3) 1,624 58 0.81 (0.48–1.36) 0.65 (0.40–1.07)
ptrend 0.223 0.128
Number of active years
\7 years 721 36 1.24 (0.76–2.04) 1.00
7–14 years 1,537 56 1.13 (0.70–1.81) 0.95 (0.56–1.63)
C14 1,975 64 0.76 (0.48–1.20) 0.68 (0.40–1.16)
ptrend 0.195 0.109
After age 30 Sports activity
Never 2,619 112 1.00 –
Ever 3,306 106 0.63 (0.44–0.91)
Mean MET hours/week
Low (\11.0) 1,176 31 0.55 (0.34–0.90) 1.00
Medium (11.0–21.0) 1,080 35 0.70 (0.44–1.14) 1.27 (0.73–2.24)
High (C21.0) 1,050 40 0.68 (0.43–1.09) 1.24 (0.70–2.19)
ptrend 0.157 0.509
Mean hours/week
Low (\2.0) 1,180 30 0.53 (0.32–0.86) 1.00
Medium (2.0–3.0) 829 30 0.80 (0.47–1.36) 1.53 (0.83–2.83)
High (C3.0) 1,297 46 0.66 (0.42–1.04) 1.25 (0.71–2.20)
ptrend 0.135 0.574
Number of active years
\5 year 938 30 0.52 (0.32–0.85) 1.00
5–11 years 951 37 0.78 (0.48–1.26) 1.29 (0.61–2.71)
C11 1,417 39 0.64 (0.39–1.03) 1.03 (0.61–1.73)
ptrend 0.119 0.990
Missing values (\4%) were coded as an additional level to include as many participants as possible for the adjustment factors. Test for trend were
conducted on the medians of the categories of sports activity
a For these analyses we excluded women who were censored/diagnosed before the age of 30 (n = 91; 29 cases)
HR Hazard ratio, CI confidence interval
b A weighted time-varying Cox proportional hazards model, stratified for genes (BRCA1 and BRCA2) and birth cohort (\1943, 1943–1954,
1955–1963, [1963), and clustered on family (387 clusters) with never sports activity as the reference category. The models are adjusted for use
of oral contraceptives (never/ever), parity (nulliparous, 1–2 children, [2 children), menopausal status (premenopausal, natural menopause,
surgical prophylactic, surgical ovarian cancer; time-varying), HRT use (never/ever), age-specific BMI (\22, 22–25, C25 kg/m2; time-varying),
BMI at age 18 (\19.6, 19.6–21.8, C21.8 kg/m2), and alcohol consumption (never/ever)
c As model bwith the lowest sports activity category as the reference category and adjusted for activity (yes/no). The models for mean MET
hours/week and mean hours/week were additionally adjusted for number of active years, and the models for number of active years were
additionally adjusted for mean MET hours/week
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Discussion
The results of this first large study specifically investigating
physical activity and breast cancer risk in BRCA1/2 muta-
tion carriers indicate that sports activity may reduce the risk
of breast cancer in BRCA1/2 mutation carriers. Among
women who had ever participated in sports activity, a
medium versus low level of intensity and duration (mean
MET hours/week in the active period) reduced the risk of
breast cancer (HR = 0.64) but a higher activity level was
not associated with a stronger risk reduction. Mean hours of
sporting per week was associated with a nonsignificant risk
reduction, while number of years engaged in sports activity
did not appear to be associated with breast cancer risk.
Among women who had participated in sports before age
30, trends for lower breast cancer risk with increasing mean
MET hours/week, hours/week, or number of active years
were observed. For sports activity after age 30, being active
was associated with lower breast cancer risk (HR = 0.63)
but no dose–response trends were found.
One of the two studies [6, 17] on physical activity and
breast cancer risk in BRCA1/2 mutation carriers found an
association and the other did not. The literature on physical
activity and breast cancer risk in the general population [9]
indicates a risk reduction of 25–30%, independent of BMI,
with a dose–response effect (for each additional hour of
activity per week the risk decreased by 6%). Stronger
decreases in risk were reported for, among others, recrea-
tional activity, lifetime or later life activity, vigorous
activity, among postmenopausal women, women with
normal BMI, and those with hormone receptor-negative
tumors [13]. The results of our study among BRCA1/2
mutation carriers are generally in line with the literature on
the general population.
Sports activity may inversely be related to other mea-
sured and unmeasured physical activity dimensions. We
also collected, although less extensively, information on
occupational, household, and walking/cycling activity. We
adjusted lifetime sports activity analyses for occupational
activity (mean MET hours/week in active period), but none
Table 4 Recent sports activity and the risk of breast cancer in different time windows (N = 725)
Time windowa
Multivariateb
HR (95% CI)
1 yeara
HR (95% CI)
2 yearsa
HR (95% CI)
5 yearsa
HR (95% CI)
10 yearsa
Recent sports activity
No 1.00 1.00 1.00 1.00
Yes 0.78 (0.55–1.09) 0.76 (0.55–1.07) 0.79 (0.57–1.09) 0.77 (0.55–1.08)
Mean MET hours/week
Low (\10.0) 0.64 (0.37–1.12) 0.64 (0.38–1.07) 0.64 (0.42–0.98) 0.73 (0.49–1.09)
Medium (10.0–21.0) 0.80 (0.50–1.28) 0.74 (0.46–1.20) 0.91 (0.56–1.50) 0.70 (0.41–1.20)
High (C21.0) 0.88 (0.55–1.41) 0.93 (0.58–1.49) 0.92 (0.57–1.50) 0.95 (0.59–1.54)
Mean hours/week
Low (\2.0) 0.48 (0.26–0.87) 0.49 (0.29–0.85) 0.70 (0.47–1.03) 0.70 (0.48–1.03)
Medium (2.0) 0.90 (0.55–1.47) 0.89 (0.52–1.50) 0.71 (0.34–1.49) 0.55 (0.16–1.94)
High (C3.0) 0.90 (0.58–1.40) 0.94 (0.61–1.44) 0.99 (0.63–1.55) 0.83 (0.53–1.30)
Percent active yearsc
B50% – 0.43 (0.15–1.25) 0.59 (0.31–1.12) 0.63 (0.41–0.97)
[50% 0.78 (0.55–1.09) 0.80 (0.57–1.13) 0.83 (0.59–1.17) 0.84 (0.58–1.22)
Missing values (\4%) were coded as an additional level to include as many participants as possible for the adjustment factors
HR Hazard ratio, CI confidence interval
a Age-specific mean sports activity (time-varying) in 1, 2, 5, and 10 year time windows. Example for the 5-year time-window: mean MET hours/
week at age 35 is (R(MET hours/week at ages 35, 34, 33, 32, and 31))/5
b A weighted time-varying Cox proportional hazards model, stratified for genes (BRCA1 and BRCA2) and birth cohort (\1943, 1943–1954,
1955–1963, [1963), and clustered on family (404 clusters) with never sports activity as the reference category. The models are adjusted for use
of oral contraceptives (never/ever), parity (nulliparous, 1–2 children, [2 children), menopausal status (premenopausal, natural menopause,
surgical prophylactic, surgical ovarian cancer; time-varying), HRT use (never/ever), age-specific BMI (\22, 22–25, C25 kg/m2; time-varying),
BMI at age 18 (\19.6, 19.6–21.8,C 21.8 kg/m2), and alcohol consumption (never/ever)
c The percentage of active years within the time window under investigation (e.g., for time window 1, B50 and [50% equals no and yes sports
activity in that period, respectively; for time window 2, B50 and [50% equals 1 and 2 years of sports activity, respectively)
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of the aspects of occupational activity showed any signif-
icant associations with breast cancer risk (data not shown).
In the Netherlands, walking and cycling is an important
source of daily physical activity, e.g., grocery shopping by
foot and going to school or work by bicycle. Because the
total amount of walking/cycling is composed of many
varying small amounts, walking/cycling is hard to report
over a lifetime, although it certainly contributes to a higher
background level of physical activity compared to studies
in other countries. Because it was not feasible to collect
lifetime information on walking/cycling and household
activities, we assessed these activities for the year prior to
questionnaire completion only, to be able to investigate the
association with all aspects of physical activity in future
prospective studies. We did not find a difference in the
amount of time spent on walking/cycling or household
activities in the year prior to the questionnaire completion
between women who did and did not participate in sports
activity (data not shown). This suggests that the other
physical activity dimensions have not affected our risk
estimates.
For lifetime sports activity, reduced risks were found for
mean MET hours/week and hours/week and were less clear
for number of active years. It was difficult to investigate
the true separate effects of mean MET hours/week and
hours/week (and to a lesser extent number of active years),
because these were highly correlated (Pearson’s r = 0.86,
p \ 0.001, v2 p \ 0.001) and the number of women with
only vigorous sports activity was too small for a separate
analysis. Our age-specific and recent sports activity anal-
yses indicate that engaging in sports activity throughout
life is important, because the observed associations were
not limited to recent activity.
Despite the predominantly negative estrogen receptor
status of BRCA1 breast cancers [30, 31], BRCA-related
breast cancer is a hormone-sensitive tumor. This is
reflected by, for example, the reduced risk of breast cancer
in carriers who underwent prophylactic (salpingo-)oopho-
rectomy [32]. Also, in vitro studies indicate that estrogens
may play a role in BRCA1-related carcinogenesis [33]. In
the general population, proposed mechanisms for a pro-
tective effect from physical activity are decreased lifetime
exposure to estrogens and decreased percent of visceral
body fat [34–36]. Furthermore, in the general population,
the association between physical activity and breast cancer
risk is most pronounced for postmenopausal and weaker for
premenopausal breast cancer [9]. However, the evidence
that physical activity may protect against premenopausal
breast cancer is increasing [14–16]. Our study, which had
most power for premenopausal breast cancer (71% of
cases), adds to this evidence; the analysis restricted to the
premenopausal period gave essentially the same results
(data not shown) as for pre- and postmenopausal women
together. An analysis restricted to postmenopausal women
lacked power (N = 308; 63 cases). It is hypothesized that
the risk reduction could be stronger after menopause
because physical activity influences both endogenous hor-
mone exposure and obesity, which has an independent
association with breast cancer risk [37, 38]. Whether this
difference also exists for BRCA1/2 mutation carriers is not
yet known. The confounding effects of BMI at age 18 and
age-specific BMI (time-varying) in the present study were
small but enough to include them as covariates. We found
no clear effect modification by BMI.
Several strong and weak points of our study should be
considered in the interpretation of these results. Strengths
of our study include, among others, the detailed informa-
tion on lifetime sports activity, the medical confirmation of
nearly all breast cancer diagnoses, the weighted cohort
approach [29], the adjustment for age-varying BMI, and
the high response rate suggesting that selection bias due to
nonresponse is not likely in our study. However, the ret-
rospective character of our cohort and the type of study
population, consisting of carriers tested in the clinical
setting, may have caused some biases in our results.
Even though we already reduced potential survival bias
by restricting the analysis to person-years within 10 years
prior to questionnaire completion, some survival bias may
have affected our results, i.e., because relatively inactive
BRCA1/2 carriers with early-onset breast cancer and a poor
prognosis may not have survived 10 years to participate in
our study. Comparison of the HRs for ever lifetime sports
activity and the risk of breast cancer between the entire
cohort (HR = 1.21, 95%CI = 0.94–1.57; data not shown)
and the analytic cohort (HR = 0.84, 95%CI = 0.57–1.24),
indeed suggested that survival bias might be present in our
entire cohort. Hence, we cannot exclude the possibility of
some survival bias in our results based on the analytic
cohort. However, we were able to include information on
deceased carriers through proxies. Unfortunately, a large
proportion of proxy questionnaires had to be excluded
because of incomplete physical activity information,
resulting in the use of only 12% (n = 37/299) of the data of
eligible proxies. An incident or a stricter analytic cohort
(i.e., 5-year) analysis was not possible because the number
of cases was too small (n = 14 incident cases).
Although our questionnaire was based on a validated
questionnaire [39], measuring lifetime physical activity is
difficult and, therefore, all studies suffer to a greater or lesser
extent from (nondifferential) misclassification bias. Non-
differential misclassification may have resulted in some bias
toward unity. Differential misclassification (recall bias) as an
explanation for the risk reductions observed would imply
that case subjects underreported their sports activities more
frequently than noncases. This does not seem likely, because
as shown in the Nurses’ Health Study [40], cases tended to
242 Breast Cancer Res Treat (2010) 120:235–244
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underreport their activity less than controls. Furthermore,
clinically tested unaffected BRCA1/2 carriers may be con-
sidered to be as health conscious as affected carriers.
We observed a significant risk reduction for ever par-
ticipating in sports activity after age 30 while for sports
activity before age 30, we only observed risk reductions
among active women. Additionally, we found nonsignifi-
cantly increased risks for the lowest categories of all three
measures of sports activity when compared to no sports
activity before age 30. Recall of physical activity in the
distant past may be more difficult than recalling recent
activities [41]. Cases might be more motivated to report
relatively short periods of sport activity in the distant past
(or at relatively young ages) than noncases while for recent
activity, quality of recall may be more equal for cases and
noncases. Also, changes in physical activity after breast
cancer diagnosis may to some extent have affected reported
prediagnostic physical activity.
In conclusion, our results indicate that sports activity
may reduce the risk of breast cancer in BRCA1/2 mutation
carriers. However, more research is needed focusing on
prospective follow-up of our cohort and similar cohorts in
other countries before a definitive conclusion can be drawn
and specific recommendations can be made.
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